Paper Details

  1. Home
  2. Paper Details

Mycophenolate for persistent complex regional pain syndrome, a parallel, open, randomised, proof of concept trial.

Author: AlexanderGuillermo, BassettPaul, FrankBernhard, GoebelAndreas, JacobAnu, MootsRobert, PhilipsCeri, SaccoPaul

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

A study of patients with persistent complex regional pain syndrome (CRPS) found that mycophenolate may be a feasible and effective treatment for CRPS.
Paper Details　
Original Abstract of the Article :
Current therapies for persistent complex regional pain syndrome (CRPS) are grossly inadequate. With accruing evidence to support an underlying immunological process and anecdotal evidence suggesting potential efficacy of mycophenolate, we wished to explore the feasibility and effectiveness of this t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/29794285

データ提供：米国国立医学図書館（NLM）

Mycophenolate: A Potential Treatment for Persistent Complex Regional Pain Syndrome?

Persistent complex regional pain syndrome (CRPS), a debilitating chronic pain condition, poses a significant challenge for healthcare providers. Current treatment options are often inadequate, highlighting the need for new and effective therapies. This study explores the potential of mycophenolate, an immunosuppressant, to treat persistent CRPS. The authors conducted a parallel, open, randomized, proof-of-concept trial to investigate the feasibility and effectiveness of mycophenolate in patients with CRPS. Their findings provide valuable insights into the potential of mycophenolate as a novel treatment option for this complex condition.

Mycophenolate: A Promising Approach for Persistent CRPS

The study's findings are encouraging, suggesting that mycophenolate might be a feasible and effective treatment for persistent CRPS. The results of this proof-of-concept trial warrant further investigation, as they highlight the potential benefits of mycophenolate in managing this debilitating condition. This research offers a glimmer of hope for patients with CRPS, who often struggle to find effective pain relief.

Navigating the Path to Pain Relief: A Hopeful Journey

The study's findings offer a glimpse into the potential of mycophenolate for treating persistent CRPS. Further research is essential to confirm its efficacy and to explore its role in managing this complex condition. The study serves as a reminder of the importance of exploring novel treatment options for debilitating chronic pain conditions, offering hope for a future where patients can find effective pain relief.

Dr.Camel's Conclusion

Like a desert oasis that provides respite from the scorching sun, mycophenolate holds promise for offering relief to those suffering from the relentless heat of persistent CRPS. This study is a valuable stepping stone on the journey towards new and effective treatments for this debilitating condition.

Date :
  1. Date Completed 2019-03-25
  2. Date Revised 2021-02-13
Further Info :

Pubmed ID

29794285

DOI: Digital Object Identifier

sjpain-2017-0154

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.